Project Details
| Short title | HLX60HLX10-FIH101 |
|---|---|
| Status | Active |
| Effective start/end date | 8/09/22 → 7/09/27 |
CTU: A Phase 1 Clinical Study to Investigate the Safety, Tolerability and Efficacy of HLX60 (Anti-GARP Monoclonal Antibody) Combination with HLX10 (Anti-PD-1 Monoclonal Antibody) in Subjects with Advanced or Metastatic Solid Tumors
- Park, John (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research